Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
5 000 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Based on the test results, Acid Orange 8 can be considered to have the following results:

No Adverse Effect level for acute toxicity oral, LD50 > 5000 mg/kg

Justification for selection of acute toxicity – oral endpoint

OECD 401

Justification for selection of acute toxicity – inhalation endpoint

waiving

Justification for classification or non-classification

Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1 of CLP Regulation (EC n. 1272/2008).

Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).

No classification for acute toxicity oral is warranted under CLP Regulation (EC n. 1272/2008).

Categories Display